Patents by Inventor Kelly L. Damm

Kelly L. Damm has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INHIBITORS OF ANTIGEN PRESENTATION BY HLA-DR
    Publication number: 20230150985
    Abstract: Chromanone compounds, pharmaceutical compositions containing them, methods of making them, and methods of using them including methods for treating disease states, disorders, and conditions associated with the inhibition of antigen presentation by HLA-DR.
    Type: Application
    Filed: March 30, 2021
    Publication date: May 18, 2023
    Inventors: Joseph Kent Barbay, Stephane Becart, Kelly L. Damm-Ganamet, Gavin C. Hirst, Kevin D. Kreutter, Alec D. Lebsack
  • COMPOSITIONS AND METHODS RELATING TO HIV PROTEASE INHIBITION
    Publication number: 20110105477
    Abstract: The present invention relates to HIV protease, and methods for inhibiting the function of HIV protease. In particular, present invention provides compounds that inhibit or block the biological activity of HIVp, thereby causing the replication of the HIV virus to be inhibited or to terminate. These compounds, as well as pharmaceutical compositions that contain these compounds and optionally other anti-viral agents as active ingredients, are suitable for treating patients or hosts infected with the HIV virus, which is known to cause AIDS. The compounds and formulations also find use in diagnostic and research settings.
    Type: Application
    Filed: September 12, 2008
    Publication date: May 5, 2011
    Applicant: The Regents of the University of Michigan
    Inventors: Heather A. Carlson, Kelly L. Damm, Kristen L. Meagher